πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7879909

Use of Treprostinil to treat neuropathic diabetic foot ulcers

United Therapeutics Corporation Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7879810

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7875450

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7875262

Aqueous starch-oil dispersions having improved UV stability and absorbing ability

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7871986

Methods of stimulating an immune response against prostate specific antigen

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7872110

Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV

United Biomedical, Inc. Β· Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7871981

Inhibition of cell motility, angiogenesis, and metastasis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7867974

Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7867983

Methods to protect skeletal muscle against injury

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7867977

Immunogenic peptides and methods of use for treating and preventing cancer

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7867500

Cofactor that modulates steroid receptor activities

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7863041

Rabies virus vector systems and compositions and methods thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7863262

Nitroxyl progenitors in the treatment of heart failure

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7862815

Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 pep

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7855276

Framework residue substituted humanized COL-1 antibodies and their use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7855076

Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7851194

West Nile viruses with mutations in the 3β€² terminal stem and loop secondary structure for

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7851169

Compositions and methods for inhibiting squamous cell carcinoma

The United States of America as represented by the Department of Veterans Affairs Office of the General Counsel Β· Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7846454

Cloned genomes of infectious hepatitis C viruses and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7846675

Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7846455

Attenuated chimeric respiratory syncytial virus

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7846450

Melanoma associated peptide analogues and vaccines against melanoma

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7842798

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7842729

Anti tubercular drug: compositions and methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted